NORTHBROOK, Ill., Dec. 21, 2016 /PRNewswire/ -- Astellas US, LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced that the company's global President and CEO Yoshihiko Hatanaka will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco, Calif. The presentation will take place at The Westin St. Francis at 2 p.m., with a question and answer session occurring from 2:30 – 2:55 p.m. PST.
To access a live webcast of the presentation, visit the Astellas Web site at: http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22611
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/astellas-to-present-at-jp-morgan-healthcare-conference-300382218.html
SOURCE Astellas US, LLC